The Fibromyalgia Treatment Market Share is all set to witness a CAGR of 6.9% and reach US$ 1.2 Bn between 2021-2031. The present-day scenario is such that mobile technology has elevated patient care and empowered clinicians. The scenario is expected to continue even going forward. Tech-savvy patients have emerged and transformed the healthcare vertical digitally.
A strong product pipeline and increasing occurrence of fibromyalgia are the major factors that are projected to boost demand for fibromyalgia treatment over the coming years. Fibromyalgia is characterized by musculoskeletal pain along with anxiety, depression, headaches, irritable bowel syndrome, memory and mood issues, sleep disorders, and fatigue. It is accepted that fibromyalgia modifies the pain sensation mechanism controlled by the brain.
As indicated by the National Institute of Health (NIH), around 1.5 billion individuals experienced chronic pain in 2016. Unhealthy lifestyles, sub-optimal diets, and undesirable lack of physical exercise are broadly increasing the danger of chronic pain. Different factors such as rising instances of rheumatic diseases, unmet medical needs, growing awareness among the population, rising geriatric population, and increasing popularity of Chinese therapy options are driving the development of the market.
Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/32455
Key players are concentrating on research & development activities to present new products in the market and provide more treatment options. Launch and approval of new fibromyalgia treatment drugs are anticipated to aid market expansion in the future.
The global fibromyalgia treatment market is estimated to be valued at US$ 1.2 Bn in 2021 and is expected to exhibit a CAGR of around 7% over the forecast period (2021 – 2031).
Companies covered in Fibromyalgia Treatment Market Report
- Pfizer, Inc.
- Eli Lilly and Company
- AbbVie, Inc.
- Teva Pharmaceutical Industries Ltd
- Sanofi
- GlaxoSmithKline plc.
- Bayer AG
- TONIX Pharmaceuticals Holdings Corp
- Virios Therapeutics, Inc.
- Aptinyx Inc.
- FSD Pharma
Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/32455
Key Takeaways from Market Study
- Under products, anticoagulants hold the highest value in the market, as they help provide relief from pain and treat the same for a long term.
- By distribution channel, hospital pharmacies hold a notable revenue share of around 46%.
- North America accounted for a share of over 40% in 2020 to become the most lucrative among all regions, and is expected to show significant growth over the next ten years.
- Europe is the next dominating region with a market share of 20% in 2020, due to well-developed medical infrastructure largely supported by governments in the region.
“Increasing burden of chronic pain, rising incidence of traumatic stress and road accidents, growing awareness among the population, and increasing research & development activities are all expected to drive market growth,” says a Persistence Market Research analyst.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/32455
Collaborations and Acquisitions – Imperative Strategy for Market Players
Major companies are actively engaging in acquisitions and expansion in order to enhance their product portfolios and outreach to a large number of customers. Globally, leading companies, in order to maintain their market position, follow the trend of acquiring companies who are facing a large number of product recalls.
In May 2020, AbbVie acquired Allergan plc, which helped the company broaden its existing portfolio and strengthen its presence in the global biopharmaceutical sector.
In October 2020, FDS BioSciences, Inc. acquired a U.S.-based company, Prismic Pharmaceuticals, which is engaged in developing novel therapies for fibromyalgia treatment.
What else is in the report?
Persistence Market Research offers a unique perspective and actionable insights on the fibromyalgia treatment market in its latest study, presenting historical demand assessment of 2016-2020 and projections for 2021-2031, based on the product (anti-depressants, anticonvulsants, muscle relaxants, and analgesics) and distribution channel (hospital pharmacies, retail pharmacies, drug stores, and online sales), across seven key regions of the world.
Access Related Reports:
E-Prescribing Market:
According to a new market report published by Persistence Market Research “Global Market Study on E-Prescribing: North America to Witness Highest Growth by 2019,” the global E-Prescribing market was valued at USD 250.2 million in 2013 and is expected to grow at a CAGR of 23.5% from 2013 to 2019, to reach an estimated value of USD 887.8 million in 2019.
Gene Expression Analysis Market:
According to the recently-published report by Persistence Market Research, the global market for gene expression analysis will reflect a steady growth during the forecast period, 2017-2022. By the end of 2022, the global gene expression analysis market is predicted to surpass US$ 4,500 Mn valuation, reflecting a robust CAGR in terms of revenues.
Botulinum Toxin Market:
Whether it is a 40+ woman worried about the wrinkles and fine lines on her skin or a patient suffering from chronic migraines and excessive sweating, the whole world swears by botulinum toxin as the ultimate go-to remedy that promises instant and long-lasting relief.
Orthopedic Veterinary Implants Market:
Increasing focus on pet health insurance is also identified as an important factor driving the market for orthopedic veterinary implants. The global orthopedic veterinary implants market will exhibit a robust CAGR of over 8% during the forecast period (2019 – 2029).
About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com